Bill > HR166

This resolution encourages the Alabama Medicaid Agency to investigate the financial implications of covering GLP-1 medications, which are drugs used for weight management and can help individuals at risk for serious health issues like heart disease and diabetes, especially given the significant economic burden obesity already places on the state. The agency is asked to determine potential cost savings for the Medicaid program if these medications are covered, consider these costs alongside new drug pricing models being explored by the Centers for Medicare and Medicaid Services (CMS), engage with healthcare providers and other stakeholders to ensure the best health outcomes and cost-effectiveness for Alabama, and then report its findings to the Legislature before the 2027 legislative session.

https://alison.legislature.state.al.us/bill-search